Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: Q4Q394
Term | Name | Level | Count |
---|---|---|---|
GO:0009987 | cellular process | 1 | 7 |
GO:0022613 | ribonucleoprotein complex biogenesis | 4 | 7 |
GO:0042254 | ribosome biogenesis | 5 | 7 |
GO:0044085 | cellular component biogenesis | 3 | 7 |
GO:0071840 | cellular component organization or biogenesis | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 259 | 263 | PF00656 | 0.570 |
CLV_C14_Caspase3-7 | 370 | 374 | PF00656 | 0.748 |
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.490 |
CLV_NRD_NRD_1 | 292 | 294 | PF00675 | 0.781 |
CLV_NRD_NRD_1 | 355 | 357 | PF00675 | 0.682 |
CLV_NRD_NRD_1 | 442 | 444 | PF00675 | 0.761 |
CLV_NRD_NRD_1 | 464 | 466 | PF00675 | 0.812 |
CLV_NRD_NRD_1 | 497 | 499 | PF00675 | 0.607 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.490 |
CLV_PCSK_KEX2_1 | 292 | 294 | PF00082 | 0.812 |
CLV_PCSK_KEX2_1 | 343 | 345 | PF00082 | 0.758 |
CLV_PCSK_KEX2_1 | 355 | 357 | PF00082 | 0.610 |
CLV_PCSK_PC1ET2_1 | 343 | 345 | PF00082 | 0.711 |
CLV_PCSK_SKI1_1 | 155 | 159 | PF00082 | 0.277 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 466 | 470 | PF00082 | 0.780 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.284 |
DEG_SPOP_SBC_1 | 297 | 301 | PF00917 | 0.653 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 227 | 236 | PF00134 | 0.485 |
DOC_MAPK_gen_1 | 12 | 19 | PF00069 | 0.454 |
DOC_MAPK_gen_1 | 154 | 160 | PF00069 | 0.477 |
DOC_MAPK_gen_1 | 21 | 31 | PF00069 | 0.477 |
DOC_MAPK_MEF2A_6 | 24 | 31 | PF00069 | 0.477 |
DOC_USP7_MATH_1 | 139 | 143 | PF00917 | 0.507 |
DOC_USP7_MATH_1 | 243 | 247 | PF00917 | 0.627 |
DOC_USP7_MATH_1 | 296 | 300 | PF00917 | 0.737 |
DOC_USP7_MATH_1 | 434 | 438 | PF00917 | 0.668 |
DOC_USP7_UBL2_3 | 24 | 28 | PF12436 | 0.517 |
DOC_USP7_UBL2_3 | 462 | 466 | PF12436 | 0.828 |
DOC_USP7_UBL2_3 | 499 | 503 | PF12436 | 0.771 |
LIG_14-3-3_CanoR_1 | 180 | 189 | PF00244 | 0.503 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.618 |
LIG_BRCT_BRCA1_1 | 216 | 220 | PF00533 | 0.471 |
LIG_deltaCOP1_diTrp_1 | 516 | 522 | PF00928 | 0.693 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.507 |
LIG_FHA_2 | 80 | 86 | PF00498 | 0.535 |
LIG_LIR_Gen_1 | 56 | 67 | PF02991 | 0.477 |
LIG_LIR_Nem_3 | 108 | 114 | PF02991 | 0.386 |
LIG_LIR_Nem_3 | 56 | 62 | PF02991 | 0.477 |
LIG_NRBOX | 159 | 165 | PF00104 | 0.535 |
LIG_SH2_STAT3 | 435 | 438 | PF00017 | 0.650 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.535 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.499 |
LIG_SUMO_SIM_anti_2 | 113 | 119 | PF11976 | 0.477 |
LIG_SUMO_SIM_anti_2 | 15 | 21 | PF11976 | 0.315 |
LIG_TRAF2_1 | 282 | 285 | PF00917 | 0.598 |
LIG_TRAF2_1 | 490 | 493 | PF00917 | 0.678 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.495 |
LIG_UBA3_1 | 232 | 241 | PF00899 | 0.421 |
MOD_CK1_1 | 246 | 252 | PF00069 | 0.615 |
MOD_CK1_1 | 299 | 305 | PF00069 | 0.747 |
MOD_CK1_1 | 363 | 369 | PF00069 | 0.682 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.587 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.503 |
MOD_CK2_1 | 299 | 305 | PF00069 | 0.586 |
MOD_CK2_1 | 335 | 341 | PF00069 | 0.729 |
MOD_CK2_1 | 40 | 46 | PF00069 | 0.615 |
MOD_CK2_1 | 487 | 493 | PF00069 | 0.601 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.477 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.477 |
MOD_Cter_Amidation | 341 | 344 | PF01082 | 0.681 |
MOD_Cter_Amidation | 420 | 423 | PF01082 | 0.660 |
MOD_Cter_Amidation | 441 | 444 | PF01082 | 0.676 |
MOD_Cter_Amidation | 460 | 463 | PF01082 | 0.702 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.620 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.577 |
MOD_GlcNHglycan | 245 | 248 | PF01048 | 0.668 |
MOD_GlcNHglycan | 301 | 304 | PF01048 | 0.669 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.409 |
MOD_GlcNHglycan | 427 | 430 | PF01048 | 0.746 |
MOD_GSK3_1 | 202 | 209 | PF00069 | 0.530 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.649 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.664 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.664 |
MOD_N-GLC_1 | 329 | 334 | PF02516 | 0.724 |
MOD_N-GLC_1 | 363 | 368 | PF02516 | 0.679 |
MOD_N-GLC_1 | 425 | 430 | PF02516 | 0.729 |
MOD_NEK2_1 | 149 | 154 | PF00069 | 0.499 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.612 |
MOD_PIKK_1 | 116 | 122 | PF00454 | 0.474 |
MOD_PIKK_1 | 124 | 130 | PF00454 | 0.482 |
MOD_PIKK_1 | 434 | 440 | PF00454 | 0.721 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.497 |
MOD_PKA_1 | 12 | 18 | PF00069 | 0.464 |
MOD_PKA_2 | 12 | 18 | PF00069 | 0.464 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.523 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.480 |
MOD_PKA_2 | 360 | 366 | PF00069 | 0.645 |
MOD_PKA_2 | 416 | 422 | PF00069 | 0.676 |
MOD_Plk_1 | 149 | 155 | PF00069 | 0.499 |
MOD_Plk_1 | 284 | 290 | PF00069 | 0.592 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.470 |
MOD_SUMO_for_1 | 27 | 30 | PF00179 | 0.517 |
TRG_NES_CRM1_1 | 138 | 150 | PF08389 | 0.477 |
TRG_NES_CRM1_1 | 389 | 400 | PF08389 | 0.596 |
TRG_NLS_MonoCore_2 | 421 | 426 | PF00514 | 0.676 |
TRG_NLS_MonoExtC_3 | 461 | 466 | PF00514 | 0.733 |
TRG_NLS_MonoExtN_4 | 420 | 427 | PF00514 | 0.651 |
TRG_NLS_MonoExtN_4 | 460 | 466 | PF00514 | 0.817 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IFC9 | Leishmania donovani | 92% | 100% |
A0A422NGQ3 | Trypanosoma rangeli | 44% | 100% |
A4HAM9 | Leishmania braziliensis | 73% | 100% |
A4I9S1 | Leishmania infantum | 93% | 100% |
E9B4T2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |